<DOC>
	<DOCNO>NCT02602483</DOCNO>
	<brief_summary>The objetive study explore efficacy safety triple combination ibuprofen , magnesium ascorbic acid acute pain treatment TMJD patient</brief_summary>
	<brief_title>Exploratory Study To Assess Efficacy Safety Triple Combination Acute Pain Treatment Patients With Temporomandibular Joint Disorders ( TMJD ) .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Temporomandibular Joint Disorders</mesh_term>
	<mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . TMD dysfunction syndrome patient RDC/TMD Groups Ia and/or Ib ( +/ IIIa and/or IIIb ) ; moderate severe pain ( VAS &gt; 4 ) , refractory conservative treatment ( include splint / local prosthesis ) 2 . Subjects 18 65 year . 3 . Body weight within normal range ( IMC index 19 30 ) express weight ( kg ) /height ( m2 ) . 4 . Physical condition accord ASA I II ( American Society Anesthesiologists ) 5 . Having participate previous clinical trial three month precede settingup study . 6 . Free acceptance collaborate study , express signature write informed consent participant 1 . Patients pregnant breastfeeding . 2 . Patients consumption enzymeinducing drug within 30 day prior study : carbamazepinam , nevirapine , phenobarbital , rifampin , secobarbital St. John 's wort . 3 . Patients consume : acetaminophen , acetyl salicylic acid , bemiparina , clonixidina , oral anticoagulant , heparin derivative , systemic corticosteroid , pemetresed , digoxin , phenytoin , lithium , methotrexate , Salicylates , NSAIDs , antacid contain aluminum , algeldrato , magaldrate , morphine derivative . Patients medicate NSAIDs Morphic derivatives treatment pain TMD prior attend consultation include whether , meet washout period 8 12 hour ( depend medication take ) include study . 4 . Patients underlie systemic pathology candidate receive drug treatment analgesic . 5 . In patient history gastrointestinal bleeding perforation relate previous treatment NSAIDs . Peptic ulcer / active recurrent gastrointestinal hemorrhage ( two episode ulceration ) proven hemorrhage . 6 . Patients active Ulcerative colitis Crohn 's disease . Severe heart failure . Severe renal dysfunction . Severe hepatic dysfunction . 7 . Patients urolithiasis oxalate 8 . History alcoholism drug dependence within 3 month prior screen visit , / , History psychotropic drug consumption within 3 month prior screen visit . 9 . Heavy consumer stimulating beverage ( &gt; 5 coffee , tea , cola drink per day ) . 10 . History drug allergy , idiosyncrasy hypersensitivity . 11 Patients cerebrovascular bleed active bleed 12 Patients bleed diathesis bleeding disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>temporomandibular</keyword>
	<keyword>joint</keyword>
	<keyword>pain</keyword>
	<keyword>ibuprofen</keyword>
	<keyword>magnesium</keyword>
	<keyword>vitamin C</keyword>
</DOC>